Research publications from the PsoProtect study group.


  1. Factors associated with adverse COVID-19 outcomes – insights from a global registry-based study. J Allergy Clin Immunology;
  2. Risk mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey. Br J Dermatol;
  3. Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study. J Eur Acad Dermatol Venereol;
  4. Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19. JAMA Network Open;
  5. Vaccine hesitancy and access to care in the COVID-19 pandemic: findings from a global patient-reported cross-sectional survey;
  6. Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic. Br J Dermatol;
  7. International collaboration and rapid harmonization across dermatologic COVID-19 registries. J Am Acad Dermatol;
  8. Learning from disease registries during a pandemic: Moving toward an international federation of patient registries. Clinics in Dermatology;
  9. Dermatology COVID-19 Registries: Updates and Future Directions. Dermatol Clin;
  10. Nonadherence to systemic immune-modifying therapy in people with psoriasis during the COVID-19 pandemic: findings from a global cross-sectional survey;
  11. Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondlyoarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries;


Infographic showing the impact of COVID-19 in People with Psoriasis Taking Drugs that Affect the Immune System.
Shielding Infographic
PsoProtect Disease Flare Infographic